Three trajectories of implementation of medications for opioid use disorder in primary care

The opioid epidemic has prompted nationwide efforts to expand access to medications for opioid use disorder (MOUD). Primary care settings have been identified as a critical access point for patients who may benefit from MOUD treatments. Despite implementation efforts, there is limited understanding of how MOUD practice capability in primary care settings evolves over time or what factors influence clinic-level implementation trajectories. We conducted a longitudinal study of 95 primary care clinics in California from 2019 to 2024. MOUD practice capability was measured using the Integrating Medications for Addiction Treatment in Primary Care (IMAT-PC) index across three timepoints. Using latent class growth analysis, we analyzed implementation growth trajectories and examined their associations with clinic characteristics and MOUD implementation outcomes (e.g., patient reach and provider adoption). Three distinct implementation trajectory classes emerged: elevated improving (41.0%), moderate improving (47.4%), and low improving (11.6%). All clinics demonstrated improvements in MOUD practice capability over time. Elevated improving clinics primarily consisted of smaller clinics (< 15,000 patients) and achieved significantly higher number of patients receiving MOUD compared to moderate (p = 0.03) and low improving clinics (p = 0.04). Clinics serving medically underserved populations disproportionately represented the low improving class (p < 0.01). Increase in the number of providers prescribing MOUD did not differ significantly across trajectory classes. Although all clinics increased MOUD capability, we found significant associations between implementation trajectory classes and changes in patients receiving MOUD over time in primary care-based MOUD programs. Implementation supports may be more effective and efficient if selected and delivered based upon clinic contextual factors, particularly in resource-constrained and underserved settings.

Authors

Institutions

Publication Details

Journal
Addiction Science & Clinical Practice
Published
2025-08-31
DOI
https://doi.org/10.1186/s13722-025-00600-y
Citations
1
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
1.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Three trajectories of implementation of medications for opioid use disorder in primary care

Wayne E. Kepner, Mark P. McGovern, Hannah R. Snyder, Noel A. Vest et al.
1 citations
Addiction Science & Clinical Practice
Opioid Use Disorder Treatment
1.88
article

Three trajectories of implementation of medications for opioid use disorder in primary care

Wayne E. Kepner, Mark P. McGovern, Hannah R. Snyder, Noel A. Vest, Hannah Cheng, Emma Risner, Brian Hurley
article en
1 citations

Abstract

The opioid epidemic has prompted nationwide efforts to expand access to medications for opioid use disorder (MOUD). Primary care settings have been identified as a critical access point for patients who may benefit from MOUD treatments. Despite implementation efforts, there is limited understanding of how MOUD practice capability in primary care settings evolves over time or what factors influence clinic-level implementation trajectories. We conducted a longitudinal study of 95 primary care clinics in California from 2019 to 2024. MOUD practice capability was measured using the Integrating Medications for Addiction Treatment in Primary Care (IMAT-PC) index across three timepoints. Using latent class growth analysis, we analyzed implementation growth trajectories and examined their associations with clinic characteristics and MOUD implementation outcomes (e.g., patient reach and provider adoption). Three distinct implementation trajectory classes emerged: elevated improving (41.0%), moderate improving (47.4%), and low improving (11.6%). All clinics demonstrated improvements in MOUD practice capability over time. Elevated improving clinics primarily consisted of smaller clinics (< 15,000 patients) and achieved significantly higher number of patients receiving MOUD compared to moderate (p = 0.03) and low improving clinics (p = 0.04). Clinics serving medically underserved populations disproportionately represented the low improving class (p < 0.01). Increase in the number of providers prescribing MOUD did not differ significantly across trajectory classes. Although all clinics increased MOUD capability, we found significant associations between implementation trajectory classes and changes in patients receiving MOUD over time in primary care-based MOUD programs. Implementation supports may be more effective and efficient if selected and delivered based upon clinic contextual factors, particularly in resource-constrained and underserved settings.

Addiction Science & Clinical PracticeVol. 20(1)
Boston University (US), Northwestern University (US), University of California, Los Angeles (US), University of California, San Francisco (US), Stanford University (US)
Department of Health Care Services, Cedars-Sinai Medical Center, National Institutes of Health, Substance Abuse and Mental Health Services Administration
Openalex Percentile: Top 12%
Opioid Use Disorder Treatment
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.